2012-04-01
Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design
Publication
Publication
Molecular Oncology , Volume 6 - Issue 2 p. 196- 203
With the event of new Molecular targets, clinical trial design requirements to perform these trials are changing. This paper discusses some of the considerations that need to be taken into account when designing a trial, including those trials that assess combinations of targets.
| Additional Metadata | |
|---|---|
| , , | |
| doi.org/10.1016/j.molonc.2012.01.009, hdl.handle.net/1765/70105 | |
| Molecular Oncology | |
| Organisation | Department of Medical Oncology |
|
Verweij, J., de Jonge, M., Eskens, F., & Sleijfer, S. (2012). Moving molecular targeted drug therapy towards personalized medicine: Issues related to clinical trial design. Molecular Oncology (Vol. 6, pp. 196–203). doi:10.1016/j.molonc.2012.01.009 |
|
